IFNG and cancer: Importantly, upon integration they appeared to be functional as they did blunt the anti-proliferative effect of trastuzumab on BT-474 cancer cells (Figure 2) and responded to IFNγ treatment with differentiation toward M1-like phenotype (Supplementary Figure S2).